Advances in Cancer Immunotherapy™

Program PurposeACI_Team.jpg

Specifically designed for clinical oncologists, registered nurses, pharmacists and the entire medical team involved in treating cancer patients with immunotherapy, the Advances in Cancer Immunotherapy™ (ACI) are introductory, CME- and CE-certified programs that provide an overview of basic immunology principles and the mechanisms and clinical applications of immunotherapy for melanoma, lung cancer and genitourinary cancers.

Presented by leading authorities in tumor immunology and cancer immunotherapy, these programs will facilitate understanding of:

  • The basic principles of tumor immunology and immunotherapy.
  • The clinical indications for immunotherapy and the appropriate selection and management of patients with melanoma, lung cancer and genitourinary cancers.
  • Emerging concepts and agents in the cancer immunotherapy field.
  • The therapeutic effectiveness of immunotherapy to ultimately improve patient outcomes. 

Attendees may also take advantage of the opportunity for professional networking that will promote collaboration and scientific exchange with experts, clinical oncologists and other healthcare providers from the surrounding community.

2017 Programs

Thank you to all who attended our 2016 Advances in Cancer Immunotherapy™ programs! The ACIs will resume in 2017, so monitor our website for future dates and locations!


ACI Online Educational Programs

As a component of our regional live programs, SITC is pleased to offer free online introductory, CME-/CE-certified programs.

The Advances in Cancer Immunotherapy™ Online programs provide an overview of basic immunology principles and the mechanisms and clinical applications of immunotherapy for melanoma, lung cancer and genitourinary cancers. If you missed the opportunity to attend a live event, you can still obtain the education and CME/CE credits through our online modules.

Access 2016 Slides and Recordings

For all SITC members and those who attended our 2016 ACI programs, click the following links to access your site-specific content of slides free of charge. All others can access program slides for a minimal charge.

Thursday, April 7 – Milwaukee, WI Thursday, June 23 – Chicago, IL
Friday, July 29 – San Diego, CA Thursday, August 18 – New York, NY
Friday, August 19 – Seattle, WA Thursday, September 8 – Boston, MA
Friday, September 30 – Baltimore, MD Thursday, October 13 – Portland, OR
Friday, October 14 – Charlottesville, VA Saturday, December 10 – Tampa, FL

Program Overview

Intended Audience

The target audience for this program series is patient care providers and others who wish to learn the basic principles of tumor immunology and immunotherapy, and to improve their ability to integrate immunotherapy into state-of-the-art clinical management for their patients. This intended audience includes clinical oncologists, registered nurses, nurse practitioners, pharmacists, allied health professionals, other patient care providers, students and patient advocates.

Educational Objectives

Upon completion of this program, participants will be able to:

  • Discuss the key mechanisms and terminology of tumor immunology and immunotherapy
  • Describe the role of immunity in cancer and approaches to tumor immunotherapy
  • Implement cancer immunotherapy treatments for melanoma, lung cancer and/or genitourinary cancers into clinical practice more effectively through a sound understanding of mechanisms of action, side effects and clinical management, and efficacy
  • Provide appropriate care and counsel for patients and their families
  • Provide accurate and appropriate counsel as part of the treatment team

Planning Committee

Asim Amin, MD, PhD – Levine Cancer Institute Carolinas Medical Center
Joseph W. Fay, MD – Baylor University Medical Center
Hideho Okada, MD, PhD – University of California San Francisco
John D. Powderly II, MD, CPI – Carolina BioOncology Institute, PLLC
Brian I. Rini, MD – Cleveland Clinic Taussig Cancer Center
Alexander Spira, MD, PhD – Virginia Cancer Specialists
Laura S. Wood, RN, MSN, OCN – Cleveland Clinic Taussig Cancer Center
Eleni Yeatras, RPh, BCOPJohns Hopkins Sidney Kimmel Cancer Center at Sibley Memorial Hospital


Attendees at the 2016 ACI in Charlottesville, Virginia.

Postgraduate Institute for MedicineSITC Logo  

Jointly provided by Postgraduate Institute for Medicine and the Society for Immunotherapy of Cancer 

The 2016 Advances in Cancer Immunotherapy™ series were supported in part by independent medical educational grants from
AstraZeneca, Bristol-Myers Squibb, Genentech, and Merck & Co., Inc.

Accessibility Image Event staff will be glad to assist you with any special needs (i.e., physical, dietary, etc.).
Please contact SITC prior to the event at (414) 271-2456.